INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 178 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q4 2015. The put-call ratio across all filers is 1.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $311,000 | -25.2% | 12,575 | +25.4% | 0.00% | 0.0% |
| Q3 2020 | $416,000 | +61.2% | 10,024 | +85.9% | 0.00% | 0.0% |
| Q2 2020 | $258,000 | -18.4% | 5,393 | +7.4% | 0.00% | 0.0% |
| Q1 2020 | $316,000 | -55.2% | 5,023 | -11.8% | 0.00% | -66.7% |
| Q4 2019 | $705,000 | +111.1% | 5,693 | +13.1% | 0.00% | +200.0% |
| Q3 2019 | $334,000 | -13.5% | 5,032 | +3.8% | 0.00% | -50.0% |
| Q2 2019 | $386,000 | -28.4% | 4,846 | +0.5% | 0.00% | 0.0% |
| Q1 2019 | $539,000 | +20.0% | 4,820 | +8.3% | 0.00% | 0.0% |
| Q4 2018 | $449,000 | -16.7% | 4,451 | +4.3% | 0.00% | 0.0% |
| Q3 2018 | $539,000 | +49.3% | 4,269 | -0.7% | 0.00% | 0.0% |
| Q2 2018 | $361,000 | +14.2% | 4,297 | -16.3% | 0.00% | 0.0% |
| Q1 2018 | $316,000 | +49.1% | 5,132 | +193.1% | 0.00% | +100.0% |
| Q2 2017 | $212,000 | -41.3% | 1,751 | -20.2% | 0.00% | -66.7% |
| Q3 2016 | $361,000 | +30.8% | 2,194 | +13.6% | 0.00% | +50.0% |
| Q2 2016 | $276,000 | 0.0% | 1,931 | -10.3% | 0.00% | 0.0% |
| Q1 2016 | $276,000 | +12.7% | 2,152 | +31.2% | 0.00% | 0.0% |
| Q4 2015 | $245,000 | +14.5% | 1,640 | +27.1% | 0.00% | 0.0% |
| Q3 2015 | $214,000 | -18.0% | 1,290 | +19.4% | 0.00% | -33.3% |
| Q2 2015 | $261,000 | – | 1,080 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Carmignac Gestion | 2,028,192 | $229,389,000 | 1.76% |
| Orbimed Advisors | 1,037,000 | $117,285,000 | 1.33% |
| BB BIOTECH AG | 255,719 | $28,922,000 | 0.95% |
| ALTRINSIC GLOBAL ADVISORS LLC | 193,369 | $21,870,000 | 0.74% |
| FALCON POINT CAPITAL, LLC | 44,573 | $5,041,000 | 0.67% |
| Rhenman & Partners Asset Management AB | 30,000 | $3,393,000 | 0.54% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 11,155 | $1,262,000 | 0.48% |
| NATIONAL PLANNING CORP | 52,400 | $5,888,000 | 0.44% |
| HIGHFIELDS CAPITAL MANAGEMENT LP | 364,232 | $41,195,000 | 0.38% |
| SPHERA FUNDS MANAGEMENT LTD. | 15,000 | $1,697,000 | 0.33% |